1. Home
  2. Stocks
  3. Ang Share Price
  • Chart
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • ANG Lifesciences India

    Small Cap
    ₹50.12
    -2.5 (-4.75%)
    27 July, 2024 11:23 BSE: 540694 NSE: ANG ISIN: INE236W01016
    Bonus

    Start SIP in ANG Lifesciences India

    Start SIP

    ANG Lifesciences India Performance

    Day Range

    • Low 0
    • High 0
    ₹ 50

    52 Week Range

    • Low 0
    • High 0
    ₹ 50
    • Open Price0
    • Previous Close0
    • Volume

    ANG Lifesciences India Share Price

    • Over 1 Month -2.3%
    • Over 3 Month -12.38%
    • Over 6 Month -30.48%
    • Over 1 Year -23.91%

    ANG Lifesciences India Key Statistics

    ANG Lifesciences India Financials
    IndicatorMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 3417305132
    Operating Expenses Qtr Cr 3019284543
    Operating Profit Qtr Cr 4-216-12
    Depreciation Qtr Cr 22223
    Interest Qtr Cr 32221
    Tax Qtr Cr 1-101-1
    Net Profit Qtr Cr -4-5-22-5
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 132217
    Operating Expenses Annual Cr 122196
    Operating Profit Annual in Cr 911
    Depreciation Cr 89
    Interest Annual Cr 910
    Tax Annual Cr 03
    Net Profit Annual Cr -9-1
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr -1326
    Cash from Investing Activity Annual Cr 20-9
    Cash from Financing Annual Activity Cr -7-17
    Net Cash Flow Annual Cr 00
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 7786
    Fixed Assets Annual Cr 5379
    Total Non Current Assets Annual Cr 5783
    Total Current Assets Annual Cr 160170
    Total Assets Annual Cr 217253
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 5966
    ROE Annual % -11-1
    ROCE Annual % 212
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 810
    IndicatorMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 3819335639
    Operating Expenses Qtr Cr 3420325050
    Operating Profit Qtr Cr 3-227-10
    Depreciation Qtr Cr 22223
    Interest Qtr Cr 43222
    Tax Qtr Cr 0001-1
    Net Profit Qtr Cr -4-6-22-5
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 147230
    Operating Expenses Annual Cr 136206
    Operating Profit Annual in Cr 1014
    Depreciation Cr 89
    Interest Annual Cr 1112
    Tax Annual Cr -13
    Net Profit Annual Cr -100
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr -926
    Cash from Investing Activity Annual Cr 20-9
    Cash from Financing Annual Activity Cr -10-17
    Net Cash Flow Annual Cr 00
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 7686
    Fixed Assets Annual Cr 5888
    Total Non Current Assets Annual Cr 6493
    Total Current Assets Annual Cr 179187
    Total Assets Annual Cr 242280
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 5866
    ROE Annual % -130
    ROCE Annual % 212
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 711
    Invest in ANG Lifesciences India

    ANG Lifesciences India Technicals

    EMA & SMA

    Current Price
    ₹50.12
    -2.5 (-4.75%)
    • Bullish Moving Average
    • ___
    • 0
    • Bearish Moving Average
    • ___
    • 0
    • 20 Day
    • ₹51.59
    • 50 Day
    • ₹52.75
    • 100 Day
    • ₹55.42
    • 200 Day
    • ₹62.07
    • 20 Day
    • ₹51.72
    • 50 Day
    • ₹52.47
    • 100 Day
    • ₹54.34
    • 200 Day
    • ₹61.52

    ANG Lifesciences India Resistance and Support

    PIVOT
    ₹51.22
    Resistance
    First Resistance 52.44
    Second Resistance 54.77
    Third Resistance 55.99
    RSI 41.99
    MFI 42.77
    MACD Single Line -0.46
    MACD -0.46
    Support
    First Support 48.89
    Second Support 47.67
    Third Supoort 45.34

    ANG Lifesciences India Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 29,418 1,868,043 63.5
    Week 13,698 948,614 69.25
    1 Month 9,739 622,836 63.95
    6 Month 13,518 926,092 68.51

    ANG Lifesciences India Result Highlights

    ANG Lifesciences India Synopsis

    NSE-Finance-Investment Mgmt

    Angel One belongs to the Industry of Finance & Investments. Company’s Total Operating Revenue is Rs. 4246.65 Cr. and Equity Capital is Rs. 84.01 Cr. for the Year ended 31/03/2024. Angel One Ltd. is a Public Limited Listed company incorporated on 08/08/1996 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L67120MH1996PLC101709 and registration number is 101709.
    Market Cap 19,191
    Sales 4,839
    Shares in Float 5.77
    No of funds 310
    Yield 1.19
    Book Value 5.97
    U/D Vol ratio 0.6
    LTDebt / Equity 1
    Alpha -0.04
    Beta 1.57

    ANG Lifesciences India Shareholding Pattern

    Owner NameJun-24Mar-24Dec-23
    Promoters 35.63%38.21%38.24%
    Mutual Funds 11.34%6.99%7.26%
    Insurance Companies 0.75%0.72%0.49%
    Foreign Portfolio Investors 15.36%17.27%19.11%
    Financial Institutions/ Banks 0.01%
    Individual Investors 31.99%31.82%30.32%
    Others 4.92%4.99%4.58%

    ANG Lifesciences India Management

    Name Designation
    Mr. Dinesh D Thakkar Chairman & Managing Director
    Mr. Ketan Shah Whole Time Director
    Mr. Amit Majumdar Whole Time Director
    Mr. Krishna Iyer Non Executive Director
    Mr. Kalyan Prasath Independent Director
    Mr. Krishnaswamy Arabadi Sridhar Independent Director
    Mr. Muralidharan Ramachandran Independent Director
    Ms. Mala Todarwal Independent Director
    Mr. Arunkumar Nerur Thiagarajan Independent Director

    ANG Lifesciences India Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    ANG Lifesciences India Corporate Action

    Date Purpose Remarks
    2024-05-30 Audited Results
    2024-02-14 Quarterly Results
    2023-11-14 Quarterly Results
    2023-08-14 Quarterly Results
    2023-05-30 Audited Results
    Date Purpose Remarks
    2021-11-04 INTERIM Rs.1.00 per share(10%)Interim Dividend
    Date Purpose Remarks
    2022-07-14 Bonus Rs.0.00 issue in the ratio of 1:4 of Rs. 10/-
    2021-09-23 Bonus Rs.0.00 issue in the ratio of 1:1 of Rs. 10/-

    ANG Lifesciences India MF Shareholding

    Name Amount(cr)

    ANG Lifesciences India FAQs

    What is Share Price of ANG Lifesciences India ?

    ANG Lifesciences India share price is ₹50 As on 27 July, 2024 | 11:09

    What is the Market Cap of ANG Lifesciences India ?

    The Market Cap of ANG Lifesciences India is ₹65.4 Cr As on 27 July, 2024 | 11:09

    What is the P/E ratio of ANG Lifesciences India ?

    The P/E ratio of ANG Lifesciences India is -6.5 As on 27 July, 2024 | 11:09

    What is the PB ratio of ANG Lifesciences India ?

    The PB ratio of ANG Lifesciences India is 0.9 As on 27 July, 2024 | 11:09

    Q2FY23
    Open Free Demat Account

    Be a part of 5paisa community - The first listed discount broker of India.

    +91
     

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI-registered Mutual Fund Distributor | AMFI REGN No.: ARN-104096 | Date of initial Registration: 30/07/2015 | Current validity of ARN : 29/07/2024 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of ₹10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of ₹10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5Paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.